Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for inhibitor I04.003: kallistatin

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: A Assay, T Target, K Knockout, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Lyu,J., Wang,S., Chen,J., Yang,X., Gao,G. and Zhou,T.<br>The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors<br>Biochim Biophys Acta Rev Cancer (2025) 1880, 189273-189273. PubMed  Europe PubMed DOI  V
    2. 2023
  2. Wang,X., Huang,X., Gao,P., Ren,Y., Li,X. and Diao,Y.<br>Kallistatin attenuates inflammatory response in rheumatoid arthritis via the NF-kappaB signaling pathway<br>Eur J Pharmacol (2023) 943, 175530-175530. PubMed  Europe PubMed DOI
    3. 2022
  3. Wang,Y., Chen,X.Y., Shang,K., Xu,Q., Li,Y.X., Du,Y. and Zhuan,L.<br>[Relationship of the kallistatin gene expression with male spermatogenic dysfunction and its possible mechanism]<br>Zhonghua Nan Ke Xue (2022) 28, 976-984. PubMed  Europe PubMed
    4. 2021
  4. Mao,Y., Qiao,J.D., Chen,S., Zhou,X., Wang,Z., Cai,S., Li,L. and Luo,Y.<br>Kallistatin Inhibits Anoikis Resistance and Metastasis of Ectopic Endometrium Cells by Modulating MnSOD and Caspase 3 Signaling<br>Reprod Sci (2021) PubMed  Europe PubMed DOI
  5. Shashidhar,K.N., Lakshmaiah,V., Muninarayana,C. and Nallagangula,K.S.<br>Quantitative ELISA for SERPINA4/kallistatin<br>Biotechniques (2021) PubMed  Europe PubMed DOI
    6. 2020
  6. Pamukcu,O., Ay,D., Uzum,K., Barlakketi,D., Kose,M., Baykan,A., Sunkak,S. and Narin,N.<br>Role of kallistatin in pediatric patients with pulmonary arterial hypertension<br>Turk J Pediatr (2020) 62, 405-410. PubMed  Europe PubMed DOI
  7. Zhuan,L., Shang,K., Guan,J., Li,Y.X., Mai,X.C. and Xu,Q.<br>[Expression of the kallistatin gene in rat corpus cavernosum]<br>Zhonghua Nan Ke Xue (2020) 26, 223-227. PubMed  Europe PubMed
    8. 2019
  8. Wu,H., Li,R., Zhang,Z., Jiang,H., Ma,H., Yuan,C., Sun,C., Li,Y. and Kong,B.<br>Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer<br>J Ovarian Res (2019) 12, 125-125. PubMed  Europe PubMed DOI  PMC  EPMC  T
    9. 2018
  9. Fruhbeck,G., Gomez-Ambrosi,J., Rodriguez,A., Ramirez,B., Valenti,V., Moncada,R., Becerril,S., Unamuno,X., Silva,C., Salvador,J. and Catalan,V.<br>Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress<br>Metabolism (2018) 87, 123-135. PubMed  Europe PubMed DOI
    10. 2017
  10. Chao,J., Li,P. and Chao,L.<br>Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress<br>Biol Chem (2017) 398, 1309-1317. PubMed  Europe PubMed DOI  V
  11. McBride,J.D., Liu,X., Berry,W.L., Janknecht,R., Cheng,R., Zhou,K., Badiavas,E.V. and Ma,J.X.<br>Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19(+) B lymphocytes in the peripheral blood<br>Int J Hematol (2017) 105, 748-757. PubMed  Europe PubMed DOI
    12. 2015
  12. Lin,F., Zhou,A. and Wei,Z.<br>Crystallization and crystallographic studies of kallistatin<br>Acta Crystallogr F Struct Biol Commun (2015) 71, 1135-1138. PubMed  Europe PubMed DOI  E
    13. 2013
  13. Liu,X., Zhang,B., McBride,J.D., Zhou,K., Lee,K., Zhou,Y., Liu,Z. and Ma,J.X.<br>Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway<br>Diabetes (2013) 62, 4228-4238. PubMed  Europe PubMed DOI  K
    14. 2010
  14. Jenkins,A.J., McBride,J.D., Januszewski,A.S., Karschimkus,C.S., Zhang,B., O'Neal,D.N., Nelson,C.L., Chung,J.S., Harper,C.A., Lyons,T.J. and Ma,J.X.<br>Increased serum kallistatin levels in type 1 diabetes patients with vascular complications<br>J Angiogenes Res (2010) 2, 19-19. PubMed  Europe PubMed DOI
    15. 2006
  15. Luo,L.Y. and Jiang,W.<br>Inhibition profiles of human tissue kallikreins by serine protease inhibitors<br>Biol Chem (2006) 387, 813-816. PubMed  Europe PubMed DOI
    16. 2003
  16. Miao,R.Q., Chen,V., Chao,L. and Chao,J.<br>Structural elements of kallistatin required for inhibition of angiogenesis<br>Am J Physiol Cell Physiol (2003) 284, C1604-C1613. PubMed  Europe PubMed DOI
  17. [YEAR:1-5-2003]Pimenta,D.C., Fogaca,S.E., Melo,R.L., Juliano,L. and Juliano,M.A.<br>Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors<br>Biochem J (1-5-2003) 371, 1021-1025. PubMed  Europe PubMed DOI  PMC  EPMC
    18. 2001
  18. Chao,J., Miao,R.Q., Chen,V., Chen,L.M. and Chao,L.<br>Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling<br>Biol Chem (2001) 382, 15-21. PubMed  Europe PubMed DOI
  19. [YEAR:12-1-2001]Chen,V.C., Chao,L., Pimenta,D.C., Bledsoe,G., Juliano,L. and Chao,J.<br>Identification of a major heparin-binding site in kallistatin<br>J Biol Chem (12-1-2001) 276, 1276-1284. PubMed  Europe PubMed DOI
  20. [YEAR:12-1-2001]Pimenta,D.C., Oliveira,A., Juliano,M.A. and Juliano,L.<br>Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin<br>Biochim Biophys Acta (12-1-2001) 1544, 113-122. PubMed  Europe PubMed DOI  A
    21. 2000
  21. [YEAR:22-12-2000]Chen,V.C., Chao,L. and Chao,J.<br>A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein<br>J Biol Chem (22-12-2000) 275, 40371-40377. PubMed  Europe PubMed DOI
  22. [YEAR:8-12-2000]Chen,V.C., Chao,L. and Chao,J.<br>Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein<br>J Biol Chem (8-12-2000) 275, 38457-38466. PubMed  Europe PubMed DOI
  23. [YEAR:15-6-2000]Chen,V.C., Chao,L. and Chao,J.<br>Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis<br>Biochim Biophys Acta (15-6-2000) 1479, 237-246. PubMed  Europe PubMed DOI
  24. Pimenta,D.C., Chen,V.C., Chao,J., Juliano,M.A. and Juliano,L.<br>Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D<br>J Protein Chem (2000) 19, 411-418. PubMed  Europe PubMed DOI
    25. 1995
  25. Chao,J. and Chao,L.<br>Biochemistry, regulation and potential function of kallistatin<br>Biol Chem Hoppe Seyler (1995) 376, 705-713. PubMed  Europe PubMed
    26. 1993
  26. [YEAR:15-11-1993]Chai,K.X., Chen,L.M., Chao,J. and Chao,L.<br>Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli<br>J Biol Chem (15-11-1993) 268, 24498-24505. PubMed  Europe PubMed
    27. 1992
  27. [YEAR:25-12-1992]Zhou,G.X., Chao,L. and Chao,J.<br>Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence<br>J Biol Chem (25-12-1992) 267, 25873-25880. PubMed  Europe PubMed
    28. 1986
  28. Chao,J., Tillman,D.M., Wang,M.Y., Margolius,H.S. and Chao,L.<br>Identification of a new tissue-kallikrein-binding protein<br>Biochem J (1986) 239, 325-331. PubMed  Europe PubMed  PMC  EPMC

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use